512 related articles for article (PubMed ID: 35867061)
41. Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua.
Kubale J; Balmaseda A; Frutos AM; Sanchez N; Plazaola M; Ojeda S; Saborio S; Lopez R; Barilla C; Vasquez G; Moreira H; Gajewski A; Campredon L; Maier HE; Chowdhury M; Cerpas C; Harris E; Kuan G; Gordon A
JAMA Netw Open; 2022 Jun; 5(6):e2218794. PubMed ID: 35759261
[TBL] [Abstract][Full Text] [Related]
42. Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS-CoV-2 Omicron wave: a cross-sectional survey.
Woldegiorgis M; Cadby G; Ngeh S; Korda RJ; Armstrong PK; Maticevic J; Knight P; Jardine A; Bloomfield LE; Effler PV
Med J Aust; 2024 Apr; 220(6):323-330. PubMed ID: 38508863
[TBL] [Abstract][Full Text] [Related]
43. Association of COVID-19 Infection With Incident Diabetes.
Naveed Z; Velásquez García HA; Wong S; Wilton J; McKee G; Mahmood B; Binka M; Rasali D; Janjua NZ
JAMA Netw Open; 2023 Apr; 6(4):e238866. PubMed ID: 37071420
[TBL] [Abstract][Full Text] [Related]
44. Characteristics of patients affecting the duration of positivity at SARS-CoV-2: a cohort analysis of the first wave of epidemic in Italy.
Milani L; Cigliano F; Catalano A; Macciotta A; Viola M; Caramello V; Costa G; Ricceri F; Sacerdote C
Epidemiol Prev; 2021; 45(6):533-542. PubMed ID: 35001598
[TBL] [Abstract][Full Text] [Related]
45. Epidemiologic Features of Recovery From SARS-CoV-2 Infection.
Oelsner EC; Sun Y; Balte PP; Allen NB; Andrews H; Carson A; Cole SA; Coresh J; Couper D; Cushman M; Daviglus M; Demmer RT; Elkind MSV; Gallo LC; Gutierrez JD; Howard VJ; Isasi CR; Judd SE; Kanaya AM; Kandula NR; Kaplan RC; Kinney GL; Kucharska-Newton AM; Lackland DT; Lee JS; Make BJ; Min YI; Murabito JM; Norwood AF; Ortega VE; Pettee Gabriel K; Psaty BM; Regan EA; Sotres-Alvarez D; Schwartz D; Shikany JM; Thyagarajan B; Tracy RP; Umans JG; Vasan RS; Wenzel SE; Woodruff PG; Xanthakis V; Zhang Y; Post WS
JAMA Netw Open; 2024 Jun; 7(6):e2417440. PubMed ID: 38884994
[TBL] [Abstract][Full Text] [Related]
46. Epidemiology of SARS-CoV-2 infection and SARS-CoV-2 positive hospital admissions among children in South Africa.
Kufa T; Jassat W; Cohen C; Tempia S; Masha M; Wolter N; Walaza S; von Gottburg A; Govender NP; Hunt G; Shonhiwa AM; Ebonwu J; Ntshoe G; Maruma W; Bapela P; Ndhlovu N; Mathema H; Modise M; Shuping L; Manana PN; Moore D; Dangor Z; Verwey C; Madhi SA; Saloojee H; Zar HJ; Blumberg L
Influenza Other Respir Viruses; 2022 Jan; 16(1):34-47. PubMed ID: 34796674
[TBL] [Abstract][Full Text] [Related]
47. Two-Year Health Outcomes in Hospitalized COVID-19 Survivors in China.
Yang X; Hou C; Shen Y; Zhang M; Zhang K; Wang F; Liu Y; Ma X; Cheng L; Kang J; Hu B; Wang M; Zeng L; Wang Y; He Y; Cao G; Jiang J; Jones P; Cao B; Li L
JAMA Netw Open; 2022 Sep; 5(9):e2231790. PubMed ID: 36107425
[TBL] [Abstract][Full Text] [Related]
48. [Short-term persistent symptoms in preschool children with mild/common coronavirus disease 2019 caused by Omicron variant infection after discharge: a follow-up study].
Hu CC; Xu P; Xu L; Zhang Y; Zhou JG; Wang LB; Zhou WH; Ye L; Lu CM
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Dec; 24(12):1289-1294. PubMed ID: 36544405
[TBL] [Abstract][Full Text] [Related]
49. International Pediatric COVID-19 Severity Over the Course of the Pandemic.
Zhu Y; Almeida FJ; Baillie JK; Bowen AC; Britton PN; Brizuela ME; Buonsenso D; Burgner D; Chew KY; Chokephaibulkit K; Cohen C; Cormier SA; Crawford N; Curtis N; Farias CGA; Gilks CF; von Gottberg A; Hamer D; Jarovsky D; Jassat W; Jesus AR; Kemp LS; Khumcha B; McCallum G; Miller JE; Morello R; Munro APS; Openshaw PJM; Padmanabhan S; Phongsamart W; Reubenson G; Ritz N; Rodrigues F; Rungmaitree S; Russell F; Sáfadi MAP; Saner C; Semple MG; Prado da Silva DGB; de Sousa LMM; Diogo Moço Souza M; Spann K; Walaza S; Wolter N; Xia Y; Yeoh DK; Zar HJ; Zimmermann P; Short KR;
JAMA Pediatr; 2023 Oct; 177(10):1073-1084. PubMed ID: 37603343
[TBL] [Abstract][Full Text] [Related]
50. Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 Months.
Admon AJ; Iwashyna TJ; Kamphuis LA; Gundel SJ; Sahetya SK; Peltan ID; Chang SY; Han JH; Vranas KC; Mayer KP; Hope AA; Jolley SE; Caldwell E; Monahan ML; Hauschildt K; Brown SM; Aggarwal NR; Thompson BT; Hough CL;
JAMA Netw Open; 2023 Feb; 6(2):e2255795. PubMed ID: 36787143
[TBL] [Abstract][Full Text] [Related]
51. Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada.
Piché-Renaud PP; Panetta L; Farrar DS; Moore-Hepburn C; Drouin O; Papenburg J; Salvadori MI; Laffin M; Kakkar F; Morris SK;
PLoS One; 2022; 17(8):e0272648. PubMed ID: 36001553
[TBL] [Abstract][Full Text] [Related]
52. Corticosteroids and Other Treatments Administered to Children Tested for SARS-CoV-2 Infection in Emergency Departments.
Freedman SB; Kuppermann N; Funk AL; Kim K; Xie J; Tancredi D; Dalziel SR; Neuman MI; Mintegi S; Plint AC; Gómez-Vargas J; Finkelstein Y; Ambroggio L; Klassen TP; Salvadori M; Malley R; Payne DC; Florin TA;
Acad Pediatr; 2022; 22(7):1200-1211. PubMed ID: 35462066
[TBL] [Abstract][Full Text] [Related]
53. Extended coagulation profile of children with Long Covid: a prospective study.
Di Gennaro L; Valentini P; Sorrentino S; Ferretti MA; De Candia E; Basso M; Lancellotti S; De Cristofaro R; De Rose C; Mariani F; Morello R; Lazzareschi I; Sigfrid L; Munblit D; Buonsenso D
Sci Rep; 2022 Nov; 12(1):18392. PubMed ID: 36319840
[TBL] [Abstract][Full Text] [Related]
54. Early Adoption of Anti-SARS-CoV-2 Pharmacotherapies Among US Veterans With Mild to Moderate COVID-19, January and February 2022.
Bajema KL; Wang XQ; Hynes DM; Rowneki M; Hickok A; Cunningham F; Bohnert A; Boyko EJ; Iwashyna TJ; Maciejewski ML; Viglianti EM; Streja E; Yan L; Aslan M; Huang GD; Ioannou GN
JAMA Netw Open; 2022 Nov; 5(11):e2241434. PubMed ID: 36367727
[TBL] [Abstract][Full Text] [Related]
55. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.
Bailey LC; Razzaghi H; Burrows EK; Bunnell HT; Camacho PEF; Christakis DA; Eckrich D; Kitzmiller M; Lin SM; Magnusen BC; Newland J; Pajor NM; Ranade D; Rao S; Sofela O; Zahner J; Bruno C; Forrest CB
JAMA Pediatr; 2021 Feb; 175(2):176-184. PubMed ID: 33226415
[TBL] [Abstract][Full Text] [Related]
56. Symptoms associated with a positive result for a swab for SARS-CoV-2 infection among children in Alberta.
King JA; Whitten TA; Bakal JA; McAlister FA
CMAJ; 2021 Jan; 193(1):E1-E9. PubMed ID: 33234533
[TBL] [Abstract][Full Text] [Related]
57. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors in children less than 6 years of age in the canton of Fribourg, Switzerland (COVPED study): a population-based cross-sectional study.
Rouge Elton PA; Schmitt PA; Faouzi M; Zimmermann P; Ritter Schenk C
Swiss Med Wkly; 2022 May; 152():w30173. PubMed ID: 35748747
[TBL] [Abstract][Full Text] [Related]
58. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort.
Ghosn J; Piroth L; Epaulard O; Le Turnier P; Mentré F; Bachelet D; Laouénan C;
Clin Microbiol Infect; 2021 Jul; 27(7):1041.e1-1041.e4. PubMed ID: 34125067
[TBL] [Abstract][Full Text] [Related]
59. [Epidemiological and clinical features of children with mild coronavirus disease 2019].
Tian JD; Xie M; Wen ZC; Xu JM; Wen C
Zhongguo Dang Dai Er Ke Za Zhi; 2021 May; 23(5):460-465. PubMed ID: 34020734
[TBL] [Abstract][Full Text] [Related]
60. Long COVID-six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: A national matched cohort study (The CLoCk) study.
Stephenson T; Pinto Pereira SM; Nugawela MD; McOwat K; Simmons R; Chalder T; Ford T; Heyman I; Swann OV; Fox-Smith L; Rojas NK; Dalrymple E; Ladhani SN; Shafran R;
PLoS One; 2023; 18(3):e0277704. PubMed ID: 36877677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
